Regulation of healthcare ethics committees in Europe
- PMID: 17520343
- PMCID: PMC2778685
- DOI: 10.1007/s11019-007-9054-6
Regulation of healthcare ethics committees in Europe
Abstract
In this article, the question is discussed if and how Healthcare Ethics Committees (HECs) should be regulated. The paper consists of two parts. First, authors from eight EC member countries describe the status quo in their respective countries, and give reasons as to the form of regulation they consider most adequate. In the second part, the country reports are analysed. It is suggested that regulation of HECs should be central and weak. Central regulation is argued to be apt to improve HECs' accountability, relevance and comparability. To facilitate biomedical citizenship and ethical reflection, regulation should at the same time be weak rather than strict. Independence of HECs to deliberate about ethical questions, and to give solicited and unsolicited advice, should be supported and only interfered with by way of exception. One exception is when circumstances become temporary adversarial to ethical deliberation in healthcare institutions. In view of European unification, steps should be taken to develop consistent policies for both Eastern and Western European countries.
References
-
- Art. L611 CSP, of the Law No. 2002-303 Regarding the Quality of Healthcare System and Patient’s Rights. 2002, France
-
- Art. L1412-6 CSP, Added by Law 2004-800 Regarding Bioethics. 2004, France; August 6, 2004
-
- The Barcelona Declaration. Policy proposals to the European Commission. November 1998 in the Biomed-II Project. Basic principles in bioethics and biolaw. http://www.ethiclaw.dk/publication/THE%20BARCELONA%20Dec%20Enelsk.pdf (accessed February 20, 2007)
-
- Beauchamp T.L., Childress J.L. 2001 Principles of Biomedical Ethics. 5th edition. Oxford: Oxford University Press
MeSH terms
LinkOut - more resources
Full Text Sources
